Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22833546 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: carfilzomib

Indicates status has not been verified in more than two years